Listing generated on 10/22/2020 at 15:23:28.
|Policy Name:||Disclosures of PHI to the FDA|
|Status:||Approved and Activated|
|Administrative Division:||Provost/VC for Academic Affairs|
|Responsible Office:||Provost/VC for Academic Affairs|
|Last Changed by:||Clemmer, Sharon Elaine on 10/03/2019|
|Policy Narrative:||PDF File|
Explains the rules governing the disclosure of PHI to the Food and Drug